2.Treatment of polymastia involving labia majora.
Shin Kyu LEE ; Ing Gon KIM ; Hee Youn CHOI ; Jai Mann LEW ; Sam Hyun JO
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1992;19(3):453-458
No abstract available.
3.On the Degranulation of Rat's Mesenteric Mast Cells Caused by Morphine and Meperidine in Vitro.
Hyun Sam SHIN ; Ho Suck KANG ; Soo Yun PARK
Yonsei Medical Journal 1971;12(1):21-27
Histological studies were carried out on the degranulation of mesenteric mast cells of albino rats in which excised pieces of rat mesentery were incubated in media containing morphine and meperidine hydrochloride. The following conclusions were obtained. 1. The experimental dose of 0.04mg./ml. of morphine hydrochloride in Tyrode solution for the incubated mesenteric pieces brought about the degranulation of mast cells. 2. The experimental dose of 0.04mg./ml. of meperidine hydrochloride in Tyrode solution for the incubation of the mesenteric pieces did not effect the cytological changes of the mast cells. 3. By the addition of metabolic inhibitor such as iodoacetic acid to the incubating medium the degranulation of the mast cells was remarkably inhibited for the group in which the incubation was carried out for 20 minutes. However, the inhibition of the degranulation of the mast cells due to the metabolic inhibitor was abolished after 30 minutes of incubation. Consequently the authors have demonstrated the effect of morphine hydrochloride in its ability to induce a degranulation of mesenteric mast cells in vitro.
Animal
;
In Vitro
;
Male
;
Mast Cells/cytology
;
Mast Cells/drug effects*
;
Meperidine/pharmacology*
;
Mesentery/cytology
;
Mesentery/drug effects*
;
Morphine/pharmacology*
;
Rabbits
4.The knowledge and attitude to the uterine cervix cancer and screening program in the patients with cervical cancer and recipients of pap smear.
Jung Hwan SHIN ; Dae Woon KIM ; Sam Hyun CHO ; Hyung MOON ; Doo Sang KIM ; Bo Youl CHOI
Korean Journal of Obstetrics and Gynecology 1993;36(2):215-225
No abstract available.
Cervix Uteri*
;
Female
;
Humans
;
Mass Screening*
;
Uterine Cervical Neoplasms*
5.Common antigenic determinants on human tumors detected by anti-fetal brain and anti-neuroblastoma monoclonal antibodies.
Hyun Chul LEE ; Jong Suk OH ; Boo Ahn SHIN ; Jinn Young KIM ; Sam Suk KANG ; Je Hyuk LEE ; Jung Hyun WOO
Korean Journal of Immunology 1991;13(1):1-15
No abstract available.
Antibodies, Monoclonal*
;
Brain*
;
Epitopes*
;
Humans*
6.Two Cases of Primary Carcinoma of the Peritoneum.
Joong Sik SHIN ; Sam Hyun CHO ; Jung Bae YOO ; Seung Ryong KIM ; Soo Hyun CHO ; Kyung Tai KIM ; Youn Yeung HWANG ; Seok Hoon JEON ; Jung Dal LEE
Korean Journal of Gynecologic Oncology and Colposcopy 1996;7(3):248-253
The primary malignant tumor of the peritoneum also known as primary peritoneal carcinoma or primary peritoneal papillary serous carcinoma is rare and involves the peritoneum, especially the pelvic peritoneum of female patients. It is difficult to differentiate histologically between papillary mesothelioma, primary ovarian tumor and primary peritoneal carcinoma. We report two cases of the primary peritoneal carcinoma with clinical presentation and histologic characteristics.
Diagnosis, Differential
;
Female
;
Humans
;
Mesothelioma
;
Peritoneum*
7.Clinico-Pathologic Study on Borderline Epithelial Tumors of the Ovary.
Sam Hyun CHO ; Seung Ryong KIM ; Hyang MOON ; Jai Auk LEE ; Youn Yeoung HWANG ; Young Jin MOON ; Dong Ik HAN ; Joong Sik SHIN ; Kyung Tal KIM
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(2):115-121
Twenty six cases of borderline ovarian tumor(BOT) were treated between Jan. 1985 and Dec. 1997 at the Department of Obstetrics and Gynecology, Hanyang University. The clinical records were reviewed for all patients including histopathology, clinical features, and follow-up. The frequency of BOT was 12%(26/214) of epithelial ovarian malignancies, and patients with these tumors tend to present at a younger age(36 yrs) than those with invasive carcinomas. In terms of histologic type, mucinous type(21/26: 81%) were more prevalent than serous tumor(5/21: 19%) in this study. The positive rate of CA 125 was 20% in serous, and the positive rate of CA 19-9 was 24% in mucinous tumor. The size of mucinous was larger than that of serous tumors(17.1 cm vs 9,3 cm). Almost all of these tumor categorized as early stage(stage I: 96%), however, only one patient with serous tumor had advanced stage of disease(stage III: 4%), Therefore BOT tend to be diagnosed as earlier than invasive carcinoma. About 2/3 of patients were treated as conservative surgery(unilateral salpingooophorectomy or enuclation). Postoperative adjuvant chemotherapy was not given about half of cases(13/26). Median follow-up was 43 months and recurrent case was found only one in serous tumor, All patients in this study are still alive and free of disease except one, 5-year survival rate was 100%. But large number of study and long-term follow-up are needed to make a decision to treat and manage of BOT.
Chemotherapy, Adjuvant
;
Female
;
Follow-Up Studies
;
Gynecology
;
Humans
;
Mucins
;
Obstetrics
;
Ovary*
;
Survival Rate
8.Effect of Cisternal Drainage on the Shunt Dependency Following Aneurysmal Subarachnoid Hemorrhage.
Sung Hun KIM ; Pil Wook CHUNG ; Yu Sam WON ; Young Joon KWON ; Hyun Chul SHIN ; Chun Sik CHOI
Journal of Korean Neurosurgical Society 2012;52(5):441-446
OBJECTIVE: Shunt-dependent chronic hydrocephalus (SDCH) is known to be a major complication associated with aneurysmal subarachnoid hemorrhage (aSAH). Old age is known to be one of numerous factors related to the development of SDCH. This study investigated whether postoperative cisternal drainage affects the incidence of SDCH and clinical outcome in elderly patients with aSAH. METHODS: Fifty-nine patients participated in this study. All patients underwent aneurysmal clipping with cisternal cerebrospinal fluid (CSF) drainage. Clinical variables relevant to the study included age, sex, location of ruptured aneurysm, CT finding and clinical state on admission, clinical outcome, and CSF drainage. We first divided patients into two groups according to age (<70 years of age and > or =70 years of age) and compared the two groups. Secondly, we analyzed variables to find factors associated with SDCH in both groups (<70 years of age and > or =70 years of age). RESULTS: Of 59 patients, SDCH was observed in 20 patients (33.9 %), who underwent shunt placement for treatment of hydrocephalus. Forty seven percent of cases of acute hydrocephalus developed SDCH. In the elderly group (> or =70 years of age), the duration and amount of CSF drainage did not affect the development of chronic hydrocephalus. CONCLUSION: In elderly patients, although the incidence of SDCH was significantly higher, clinical outcome was acceptable. The duration and the amount of cisternal drainage did not seem to be related to subsequent development of chronic hydrocephalus within elderly patients aged 70 or older.
Aged
;
Aneurysm
;
Aneurysm, Ruptured
;
Dependency (Psychology)
;
Drainage
;
Humans
;
Hydrocephalus
;
Incidence
;
Subarachnoid Hemorrhage
9.Predictability of the Survival using Prognostic Index (PI) of Patients with Epithelial Ovarian Cancer.
Sam Hyun CHO ; Seung Ryong KIM ; Hyang MOON ; Jai Auk LEE ; Youn Yeoung HWANG ; Young Jin MOON ; Joong Sik SHIN ; Kyung Tal KIM ; Chang Young CHUNG
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(2):173-182
OBJECTIVES: To predict of the survival of patients with epithelial ovarian cancer, multivariable analysis was done to identify variables with independent prognostic factors. Based on materials from 191 clinical trials performed by Department of Obstetrics and Gynecology, Hanyang University Hospital, we constructed a prognostic index (Pp with considerable predictive power for long-term survival of patients with epithelial ovatian cancer treated with cis-platin based combination chemotherapy, METHODS: On identifying variables with independent prognostic value, statistical analysis were performed with clinicopathologic variables including age, FIGO stage, histologic subtype, histologic grade, residual tumor, presence of ascites, pretreatment levels of hemoglobin, platelet, and tumor markers(CA 125, CA 19-9). We also analyzed biological variables using immunohistochemical staining for GST-pie (glutathione-s-transferase-pie), p-glycoprotein, and MT (metallothinein) as a drug resistance and uPA (urokinase type plasminogen activator), PAI-1 (plasminogen activator inhibitor-l), nm23 (nonmetastatic gene 23) as a tumor invasion and metastasis. In addition, univariable analysis was performed followed by multivariable analysis using Coxs proportional hazards model to identify variables predictive of poor prognosis. Prognostic index (PI) was calculated based on sum of individual beta-coefficient of the most important independent prognostic value. RESULTS: With univariable analysis, age, FIGO stage, histologic grade, histologic subtype, presence of ascites, residual tumor, initial value of CA 125, MT, uPA, and PAI-1 were found to predict of patients survival. In the multivariable analysis and proportional hazard model, the pretreatment characteristics needed for the calculation of the PI are the age, the site of metastases expressed as stage, the histologic subtype, the size of residual tumor, the histological grade, and the presence of ascites. In the subgroup comprising the 10% of the patients with the best prognosis, 5-year survival rate was 78.9%, whereas in the subgmup comprising the 10% with the poorest prognosis, 5-year survival rate was 7.1%, which illustrates the large variability of the prognosis among patients. CONCLUSIONS: The PI was found to retain its value after response was achieved. The information provided by the PI can be expected to be useful in treatment planning and the proper stratification of patients in clinical trials.
Ascites
;
Blood Platelets
;
Drug Resistance
;
Drug Therapy, Combination
;
Gynecology
;
Humans
;
Neoplasm Metastasis
;
Neoplasm, Residual
;
Obstetrics
;
Ovarian Neoplasms*
;
P-Glycoprotein
;
Plasminogen
;
Plasminogen Activator Inhibitor 1
;
Prognosis
;
Proportional Hazards Models
;
Survival Rate
10.Determinants of Successful Percutaneous Transluminal Coronary Angioplasty.
Kyo Won CHOI ; Jun Young KWEON ; Yeung Jin KIM ; Tae Il LEE ; Dong Gu SHIN ; Young Jo KIM ; Bong Sup SHIM ; Hyun Woo LEE ; Sam Beom LEE
Yeungnam University Journal of Medicine 1994;11(2):230-239
In Order to evaluate determinants of successful percutaneous transluminal coronary angioplasty (PTCA), PTCA was performed for 172 coronary arterial lesions in 120 patients(89 male, 31 female) at Yeungnam university hospital from Sep. 1992 to Aug 1993. The corinary artery luminal diameter at the site of the original stenosis was eveluated from end-diastolic frames of identical projections of the preangioplasty and immediate post angioplasty. The coronary luminal and balloon diameters were measured with using of computer measuring system. Overall success rate of 172 attempted lesions was 87.2%. Success rate of female patients was 93.5% and higher than those of male patients. According to the clinical diagnosis, success rate in stable angina was 93.7% and higher than those of post myocardial infarction angina, unstable angina and acute myocardial infarcrion. Success rate of American Heart Association type C lesion was 65.5% and lower those of type A(95.7%), type B (89.%). There was significantly difference in preangioplasty luminal stenosis, elastic recoil and length of lesion between successful PTCA group and failed PTCA group. Success rate of lesion location at a bed >45° and presence of intracoronary thrombus were lower than than those of other angiographic findings. In coclusion, primary angioplasty success was affected by specific angiographic factors, Stenosis severity, thrombus, lesion location at a bend >45°, elastic recoil, and length of lesion were the principle of determinants of coronary angioplasty success rate.
American Heart Association
;
Angina, Stable
;
Angina, Unstable
;
Angioplasty
;
Angioplasty, Balloon, Coronary*
;
Arteries
;
Constriction, Pathologic
;
Diagnosis
;
Female
;
Humans
;
Male
;
Myocardial Infarction
;
Phenobarbital
;
Thrombosis